(Q45057663)

9 December 2017

Potential health benefits and medical cost savings from calorie, sodium, and saturated fat reductions in the American diet (English)

1 reference

9 December 2017

1

1 reference

9 December 2017

Victor L Fulgoni

2

1 reference

9 December 2017

Yiduo Zhang

3

1 reference

9 December 2017

Kristin J Reimers

4

1 reference

9 December 2017

Patricia T Packard

5

1 reference

9 December 2017

James D Astwood

6

1 reference

9 December 2017

1 July 2009

1 reference

American Journal of Health Promotion

9 December 2017

1 reference

9 December 2017

23

1 reference

9 December 2017

6

1 reference

9 December 2017

412-422

1 reference

The direct health care costs of obesity in the United States

9 December 2017

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Economic costs of obesity and inactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Economic causes and consequences of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Obesity, health services use, and health care costs among members of a health maintenance organization.

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Current estimates of the economic cost of obesity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Overweight and obesity: prevalence, consequences, and causes of a growing public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Impact of dietary patterns and interventions on cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Cost associated with being overweight and with obesity, high alcohol consumption, and tobacco use within the military health system's TRICARE prime-enrolled population

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Obesity and hypertension: epidemiological and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Two-year changes in lipids and lipoproteins associated with the maintenance of a 5% to 10% reduction in initial weight: some findings and some questions

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Long-term weight loss effects on all cause mortality in overweight/obese populations

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Intentional weight loss and mortality among initially healthy men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

State-level estimates of annual medical expenditures attributable to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

The health economics of the treatment of hyperlipidemia and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Predicted national productivity implications of calorie and sodium reductions in the American diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Epidemiology of uncontrolled hypertension in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

The economic impact of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Economic implications of evidence-based prescribing for hypertension: can better care cost less?

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Pharmacoeconomic burden of undertreating hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

The future of antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

Health care expenditures associated with overweight and obesity among US adults: importance of age and race

21 January 2018

1 reference

https://api.crossref.org/works/10.4278%2FAJHP.080930-QUAN-226

10.4278/AJHP.080930-QUAN-226

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference